title: Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
abstract: Moloney murine leukemia virus (MLV)-derived gamma-retroviral vectors integrate preferentially near transcriptional regulatory regions in the human genome, and are associated with a significant risk of insertional gene deregulation. Self-inactivating (SIN) vectors carry a deletion of the U3 enhancer and promoter in the long terminal repeat (LTR), and show reduced genotoxicity in pre-clinical assays. We report a high-definition analysis of the integration preferences of a SIN MLV vector compared to a wild-type-LTR MLV vector in the genome of CD34(+) human hematopoietic stem/progenitor cells (HSPCs). We sequenced 13,011 unique SIN-MLV integration sites and compared them to 32,574 previously generated MLV sites in human HSPCs. The SIN-MLV vector recapitulates the integration pattern observed for MLV, with the characteristic clustering of integrations around enhancer and promoter regions associated to H3K4me3 and H3K4me1 histone modifications, specialized chromatin configurations (presence of the H2A.Z histone variant) and binding of RNA Pol II. SIN-MLV and MLV integration clusters and hot spots overlap in most cases and are generated at a comparable frequency, indicating that the reduced genotoxicity of SIN-MLV vectors in hematopoietic cells is not due to a modified integration profile.
authors: Division of Genetics and Cell Biology, Istituto Scientifico H. San Raffaele, Milan, Italy.
authors: Arianna
authors: A
authors: Moiani
authors: Annarita
authors: A
authors: Miccio
authors: Ermanno
authors: E
authors: Rizzi
authors: Marco
authors: M
authors: Severgnini
authors: Danilo
authors: D
authors: Pellin
authors: Julia Debora
authors: JD
authors: Suerth
authors: Christopher
authors: C
authors: Baum
authors: Gianluca
authors: G
authors: De Bellis
authors: Fulvio
authors: F
authors: Mavilio
mesh_terms: D000818:Animals; D019295:Computational Biology / Q000379:methods; D056426:Genetic Loci; D005822:Genetic Vectors; D015894:Genome, Human; D006412:Hematopoietic Stem Cells / Q000378:metabolism* / Q000821:virology; D006657:Histones; D006801:Humans; D051379:Mice; D008979:Moloney murine leukemia virus / Q000235:genetics*; D016254:Mutagenesis, Insertional; D011401:Promoter Regions, Genetic; D017384:Sequence Deletion; D020079:Terminal Repeat Sequences; D014161:Transduction, Genetic; D016662:Virus Integration
chemical_list: D006657:Histones
references: Retrovirology. 2008 Jun 13;5:48
references: 18554410
references: J Clin Invest. 2008 Sep;118(9):3132-42
references: 18688285
references: Nat Med. 2006 Apr;12(4):401-9
references: 16582916
references: PLoS Pathog. 2006 Jun;2(6):e60
references: 16789841
references: Blood. 2006 Oct 15;108(8):2545-53
references: 16825499
references: Cell. 2008 Nov 14;135(4):649-61
references: 18992931
references: PLoS Genet. 2007 Sep;3(9):1572-86
references: 17845075
references: Semin Cancer Biol. 2010 Aug;20(4):269-78
references: 20600920
references: Nature. 2010 Sep 16;467(7313):318-22
references: 20844535
references: Mol Ther. 2009 Nov;17(11):1910-8
references: 19638958
references: PLoS One. 2010 Dec 22;5(12):e15688
references: 21203516
references: Blood. 2007 Sep 15;110(6):1770-8
references: 17507662
references: Mol Ther. 2012 Jun;20(6):1187-95
references: 22472950
references: Nat Biotechnol. 2006 Jun;24(6):687-96
references: 16732270
references: Mol Ther. 2009 May;17(5):844-50
references: 19259065
references: Mol Ther. 2008 Apr;16(4):718-25
references: 18334985
references: Cell Stem Cell. 2009 Jan 9;4(1):80-93
references: 19128795
references: Mol Ther. 2009 Nov;17(11):1919-28
references: 19672245
references: N Engl J Med. 2009 Jan 29;360(5):447-58
references: 19179314
references: Mol Ther. 2009 May;17(5):851-6
references: 19293778
references: N Engl J Med. 2002 Apr 18;346(16):1185-93
references: 11961146
references: Science. 2005 May 20;308(5725):1171-4
references: 15905401
references: Blood. 2010 Dec 16;116(25):5507-17
references: 20864581
references: PLoS Pathog. 2008 Mar 28;4(3):e1000046
references: 18369482
references: Nucleic Acids Res. 2011 Mar;39(6):e35
references: 21177645
references: PLoS One. 2009;4(2):e4571
references: 19238208
references: Genome Res. 2007 Aug;17(8):1186-94
references: 17545577
references: Nat Med. 2010 Feb;16(2):198-204
references: 20098431
references: Gene Ther. 2011 Jul;18(7):674-81
references: 21368897
references: J Clin Invest. 2012 May;122(5):1667-76
references: 22523064
references: J Clin Invest. 2008 Sep;118(9):3143-50
references: 18688286
references: Mol Ther. 2008 Mar;16(3):590-8
references: 18180772
references: Science. 2009 Nov 6;326(5954):818-23
references: 19892975
references: Nat Rev Microbiol. 2005 Nov;3(11):848-58
references: 16175173
references: J Clin Invest. 2009 Apr;119(4):964-75
references: 19307726
references: J Clin Invest. 2012 May;122(5):1653-66
references: 22523069
references: Nat Med. 2006 Dec;12(12):1397-402
references: 17115047
references: Blood. 2005 Jun 1;105(11):4235-46
references: 15713797
references: N Engl J Med. 2010 Nov 11;363(20):1918-27
references: 21067383